In 2026, consumer wearables do more. They can flag patterns that may point to real health problems, not just a rough wellness trend.
Local tech company developing device aimed at protecting children with autism who wander from adults
Covington-based Safewave created a wearable device to help people who are deaf stay alert to their surroundings — now the ...
At ATTD 2026, Dexcom (Nasdaq:DXCM) outlined a range of ways in which its continuous glucose monitors (CGMs) benefit people with diabetes.
After years of limited workarounds and user requests, Garmin has finally launched an official, full-featured WhatsApp integration. But there are some limitations.
Unexplained hyperglycemic events may be due to undetected occlusions, a common problem that experts say needs to be addressed through education and technology.
Two major upgrades to Fitbit’s AI Coach aim to improve sleep insights and to use your medical records to inform its advice.
Diabetes technology innovators gathered last week for the Advanced Technologies and Treatments for Diabetes Conference (ATTD 2026).
Opportunities include integrating digital health for remote care, leveraging demographic trends, and overcoming CGM unit costs to expand access across regionsDublin, March 16, 2026 (GLOBE NEWSWIRE) -- ...
EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.
A tear in the tubing may prevent users from getting full insulin doses. So far 18 people have reported serious issues related ...
Medical Device Network on MSN
Dexcom gives sneak preview of CGM technologies’ long-term health benefits for diabetics
Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...
StockStory.org on MSN
Patient monitoring stocks Q3 recap: Benchmarking Masimo (NASDAQ:MASI)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q3, starting with Masimo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results